Prime Medicine expands gene editing platform
Prime Medicine has added new capabilities to its Prime gene editing platform based on new research developments. Read More
Gamida highlights poster presentations at SITC 2021
Cell therapy firm Gamida Cell is directing attention to two poster presentations at the annual meeting of the Society for Immunotherapy of Cancer (SITC) involving its nicotinamide-enabled cell expansion technology. Read More
Promega unveils Sanger sequencing chemistry system
Promega has introduced ProDye Terminator, a new sequencing system that enables research labs to perform Sanger sequencing on all capillary electrophoresis platforms. Read More
RedShift Bioanalytics nets $20M in new financing
RedShift BioAnalytics has finalized a $20 million series E funding round. The firm is developing platform technology to enable the measurement of previously undetectable structure changes in biomolecules. Read More
Stilla launches Naica 6-color digital PCR system
Stilla Technologies has launched Naica, a digital polymerase chain reaction (PCR) system that features six fluorescent channels. Naica was introduced at the American Society of Human Genetics virtual meeting. Read More
PerkinElmer, Honeycomb launch single-cell isolation and analysis tool
PerkinElmer and Honeycomb Biotechnologies have launched a new single-cell isolation and analysis tool called Hive scRNAseq. Read More
Charles River to partner with ATEM Structural Discovery
Charles River Laboratories International has inked a partnership with ATEM Structural Discovery to provide its clients with ATEM's cryoelectron microscopy service. Read More
DNA Script joins Genome Project-write's advisory board
DNA Script has joined the industrial advisory board of Genome Project-write, which has developed a computer-aided design tool for genome design. Read More
IsoPlexis raises $125M in IPO
IsoPlexis completed an initial public offering (IPO) on October 12, closing with $125 million on the sale of approximately 8.3 million shares at $15 per share. Read More
Report finds most CROs establishing digital trial models
Contract research organizations (CROs) are addressing challenges from the rapid move to decentralized research trials amid the COVID-19 pandemic, with most clinical leaders now focused on establishing digital trial models, according to a new survey from Veeva Systems. Read More
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
